//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Linzer D.G. et al. Seminal vesicle biopsy: accuracy and implications for staging of prostate cancer. Urology. 1996;48:757. https://www.ncbi.nlm.nih.gov/pubmed/8911521.

Aron M. et al. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 2000;85:682. https://www.ncbi.nlm.nih.gov/pubmed/10759665.

Von Knobloch R. et al. Bilateral fine-needle administered local anaesthetic nerve block for pain control during TRUS-guided multi-core prostate biopsy: a prospective randomised trial. Eur Urol. 2002;41:508. https://www.ncbi.nlm.nih.gov/pubmed/12074792. PROSTATE CANCER - UPDATE MARCH 2017 103.

Adamakis I. et al. Pain during transrectal ultrasonography guided prostate biopsy: a randomized prospective trial comparing periprostatic infiltration with lidocaine with the intrarectal instillation of lidocaine-prilocain cream. World J Urol. 2004;22:281. https://www.ncbi.nlm.nih.gov/pubmed/14689224.

NCCN Clinical practice Guidelines in OncologyTM: Prostate Cancer Early Detection, Version 2. 2015. 2015. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

Smeenge M. et al. Role of transrectal ultrasonography (TRUS) in focal therapy of prostate cancer: report from a Consensus Panel. BJU Int. 2012;110:942. https://www.ncbi.nlm.nih.gov/pubmed/22462566.

Turkbey B. et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol. 2011;186:1818. https://www.ncbi.nlm.nih.gov/pubmed/21944089.

Selnaes K.M. et al. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology. Invest Radiol. 2012;47:624. https://www.ncbi.nlm.nih.gov/pubmed/23011187.

Bratan F. et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol. 2013;23:2019. https://www.ncbi.nlm.nih.gov/pubmed/23494494.

//Краткое руководство по ведению пациентов с онкологическими заболеваниями мочеполовой системы


Le J.D. et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015;67:569. https://www.ncbi.nlm.nih.gov/pubmed/25257029.

Van Hove A. et al. Comparison of image-guided targeted biopsies versus systematic randomized biopsies in the detection of prostate cancer: a systematic literature review of well-designed studies. World J Urol. 2014;32:847. https://www.ncbi.nlm.nih.gov/pubmed/24919965.

Schoots I.G. et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasoundguided biopsy: a systematic review and meta-analysis. Eur Urol. 2015;68:438. https://www.ncbi.nlm.nih.gov/pubmed/25480312.

Mertan F.V. et al. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. J Urol. 2016;196:690. https://www.ncbi.nlm.nih.gov/pubmed/27101772.

Epstein J.I. et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016;40:244. https://www.ncbi.nlm.nih.gov/pubmed/26492179.

Sebo T.J. et al. Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer. 2001;1:2196. https://www.ncbi.nlm.nih.gov/pubmed/11391602.

Grossklaus D.J. et al. Percent of cancer in the biopsy set predicts pathological findings after prostatectomy. J Urol. 2002;167:2032. https://www.ncbi.nlm.nih.gov/pubmed/11956432.

Freedland S.J. et al. Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen. J Urol. 2004;171:2215. https://www.ncbi.nlm.nih.gov/pubmed/15126788.